Enjoy complimentary customisation on priority with our Enterprise License!
The cell and gene therapy market share is expected to increase by USD 9.97 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 20.15%.
This cell and gene therapy market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers cell and gene therapy market segmentations by type (cell therapy and gene therapy) and geography (North America, Europe, Asia, and Rest of World (ROW)). The cell and gene therapy market report also offers information on several market vendors, including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., bluebird bio Inc., Bristol Myers Squibb Co., Castle Creek Biosciences Inc., CORESTEM Inc., Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC., Ferring BV, Gilead Sciences Inc., Helixmith Co. Ltd., Human Stem Cells Institute, JCR Pharmaceticals Co. Ltd., Kolon TissueGene Inc., Novartis AG, Orchard Therapeutics Plc, Pfizer Inc., Sibiono GeneTech Co. Ltd., and Vericel Corp. among others.
Download Report Sample to Unlock the Cell and Gene Therapy Market Size for the Forecast Period and Other Important Statistics
The increasing prevalence of chronic diseases is notably driving the cell and gene therapy market growth, although factors such as high cost and failure rate in clinical trials may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the cell and gene therapy industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Cell and Gene Therapy Market Driver
Key Cell and Gene Therapy Market Trend
Key Cell and Gene Therapy Market Challenge
This cell and gene therapy market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global cell and gene therapy market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the cell and gene therapy market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the cell and gene therapy market encompasses successful business strategies deployed by the key vendors. The cell and gene therapy market is fragmented and the vendors are deploying growth strategies such as quality, price, market reach, and financial resources to compete in the market.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The cell and gene therapy market forecast report offer in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the cell and gene therapy market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
41% of the market’s growth will originate from North America during the forecast period. The US is the key market for the cell and gene therapy market in North America. Market growth in this region will be slower than the growth of the market in Asia.
Huge investment in R&D activities for cell and gene therapy, especially in the US will facilitate the cell and gene therapy market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 had a negative impact on the regional market. However, research institutes and healthcare facilities engaged in gene therapy have started developing new gene therapy products and treatments for individuals with cancer and other rare diseases in 2021. This, in turn, will boost the growth of the regional market during the forecast period.
To gain further insights on the market contribution of various segments Request PDF Sample
The cell and gene therapy market share growth by the cell therapy segment will be significant during the forecast period. Cell therapy is a type of treatment in which living cells are injected into a patient to cure different ailments. The demand for cell therapy treatment is increasing because their products can be used for personalized treatment. The therapeutic benefits of cell therapy products have encouraged companies to develop products from various cell lines such as stem cell-based products. Such factors of cell therapy will boost the market growth in the near future.
This report provides an accurate prediction of the contribution of all the segments to the growth of the cell and gene therapy market size and actionable market insights on the post-COVID-19 impact on each segment.
Cell and Gene Therapy Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 20.15% |
Market growth 2022-2026 |
$9.97 billion |
Market structure |
Fragmented |
YoY growth (%) |
13.65 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key consumer countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., bluebird bio Inc., Bristol Myers Squibb Co., Castle Creek Biosciences Inc., CORESTEM Inc., Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC., Ferring BV, Gilead Sciences Inc., Helixmith Co. Ltd., Human Stem Cells Institute, JCR Pharmaceticals Co. Ltd., Kolon TissueGene Inc., Novartis AG, Orchard Therapeutics Plc, Pfizer Inc., Sibiono GeneTech Co. Ltd., and Vericel Corp. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.